Viewing Study NCT05496192

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:30 PM
Ignite Modification Date: 2026-01-24 @ 7:12 AM
Study NCT ID: NCT05496192
Status: WITHDRAWN
Last Update Posted: 2023-04-14
First Post: 2022-08-09
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Nivolumab Intravenous (IV) to Subcutaneous (SC) Switch in Adjuvant Melanoma and Bladder Cancer
Sponsor: Bristol-Myers Squibb
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma View
None Urothelial Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Resected Invasive Urothelial Carcinoma View
None Nivolumab View
None Bladder View
None Melanoma View
None Adjuvant View
None Subcutaneous View